Speakers:

Barbara W. Unger

President, Unger Consulting

Areas examined in this report:

  • In-depth analysis of FDA Warning Letters issued in FY2020 and FY2021
  • FDA enforcement trends as indicated by this analysis
  • How these trends compare to enforcement trends since FY2013